JMD GMP oligos for in vitro Diagnostics
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ogino, S.
Right arrow Articles by Fuchs, C. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ogino, S.
Right arrow Articles by Fuchs, C. S.
JMD 2005, Vol. 7, No. 3
Copyright © 2005 American Society for Investigative Pathology & Association for Molecular Pathology

Sensitive Sequencing Method for KRAS Mutation Detection by Pyrosequencing

Shuji Ogino*{dagger}{ddagger}, Takako Kawasaki{dagger}, Mohan Brahmandam{dagger}, Liying Yan§, Mami Cantor{dagger}, Chungdak Namgyal{dagger}, Mari Mino-Kenudson{ddagger}, Gregory Y. Lauwers{ddagger}, Massimo Loda*{dagger}{ddagger} and Charles S. Fuchs||{dagger}{ddagger}

From the Departments of Pathology * and Medicine, || Brigham and Women’s Hospital, Boston; the Department of Medical Oncology, {dagger} Dana-Farber Cancer Institute, Boston; Harvard Medical School, {ddagger} Boston; Biotage AB and Biosystems, § Foxborough; and the Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts

Both benign and malignant tumors represent heterogenous tissue containing tumor cells and non-neoplastic mesenchymal and inflammatory cells. To detect a minority of mutant KRAS alleles among abundant wild-type alleles, we developed a sensitive DNA sequencing assay using Pyrosequencing, ie, nucleotide extension sequencing with an allele quantification capability. We designed our Pyrosequencing assay for use with whole-genome-amplified DNA from paraffin-embedded tissue. Assessing various mixtures of DNA from mutant KRAS cell lines and DNA from a wild-type KRAS cell line, we found that mutation detection rates for Pyrosequencing were superior to dideoxy sequencing. In addition, Pyrosequencing proved superior to dideoxy sequencing in the detection of KRAS mutations from DNA mixtures of paraffin-embedded colon cancer and normal tissue as well as from paraffin-embedded pancreatic cancers. Quantification of mutant alleles by Pyrosequencing was precise and useful for assay validation, monitoring, and quality assurance. Our Pyrosequencing method is simple, robust, and sensitive, with a detection limit of approximately 5% mutant alleles. It is particularly useful for tumors containing abundant non-neoplastic cells. In addition, the applicability of this assay for DNA amplified by whole-genome amplification technique provides an expanded source of DNA for large-scale studies.




This article has been cited by other articles:


Home page
 Clin. Cancer Res.Home page
S. Ogino, K. Nosho, N. Irahara, S. Kure, K. Shima, Y. Baba, S. Toyoda, L. Chen, E. L. Giovannucci, J. A. Meyerhardt, et al.
A Cohort Study of Cyclin D1 Expression and Prognosis in 602 Colon Cancer Cases
Clin. Cancer Res., July 1, 2009; 15(13): 4431 - 4438.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
S. Ogino, K. Shima, K. Nosho, N. Irahara, Y. Baba, B. M. Wolpin, E. L. Giovannucci, J. A. Meyerhardt, and C. S. Fuchs
A Cohort Study of p27 Localization in Colon Cancer, Body Mass Index, and Patient Survival
Cancer Epidemiol. Biomarkers Prev., June 1, 2009; 18(6): 1849 - 1858.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
K. Nosho, K. Shima, N. Irahara, S. Kure, Y. Baba, G. J. Kirkner, L. Chen, S. Gokhale, A. Hazra, D. Spiegelman, et al.
DNMT3B Expression Might Contribute to CpG Island Methylator Phenotype in Colorectal Cancer
Clin. Cancer Res., June 1, 2009; 15(11): 3663 - 3671.
[Abstract] [Full Text] [PDF]

Home page
 J. Mol. Diagn.Home page
L. Zhang, T. Kirchhoff, C. J. Yee, and K. Offit
A Rapid and Reliable Test for BRCA1 and BRCA2 Founder Mutation Analysis in Paraffin Tissue Using Pyrosequencing
J. Mol. Diagn., May 1, 2009; 11(3): 176 - 181.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
S. Ogino, K. Nosho, G. J. Kirkner, K. Shima, N. Irahara, S. Kure, A. T. Chan, J. A. Engelman, P. Kraft, L. C. Cantley, et al.
PIK3CA Mutation Is Associated With Poor Prognosis Among Patients With Curatively Resected Colon Cancer
J. Clin. Oncol., March 20, 2009; 27(9): 1477 - 1484.
[Abstract] [Full Text] [PDF]

Home page
 GutHome page
S. Ogino, K. Nosho, G. J Kirkner, T. Kawasaki, J. A Meyerhardt, M. Loda, E. L Giovannucci, and C. S Fuchs
CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancer
Gut, January 1, 2009; 58(1): 90 - 96.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
S. Ogino, G. J. Kirkner, K. Nosho, N. Irahara, S. Kure, K. Shima, A. Hazra, A. T. Chan, R. Dehari, E. L. Giovannucci, et al.
Cyclooxygenase-2 Expression Is an Independent Predictor of Poor Prognosis in Colon Cancer
Clin. Cancer Res., December 15, 2008; 14(24): 8221 - 8227.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
S. Ogino, K. Nosho, J. A. Meyerhardt, G. J. Kirkner, A. T. Chan, T. Kawasaki, E. L. Giovannucci, M. Loda, and C. S. Fuchs
Cohort Study of Fatty Acid Synthase Expression and Patient Survival in Colon Cancer
J. Clin. Oncol., December 10, 2008; 26(35): 5713 - 5720.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
S. Ogino, K. Nosho, G. J. Kirkner, T. Kawasaki, A. T. Chan, E. S. Schernhammer, E. L. Giovannucci, and C. S. Fuchs
A Cohort Study of Tumoral LINE-1 Hypomethylation and Prognosis in Colon Cancer
J Natl Cancer Inst, December 3, 2008; 100(23): 1734 - 1738.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
I. Fichtner, J. Rolff, R. Soong, J. Hoffmann, S. Hammer, A. Sommer, M. Becker, and J. Merk
Establishment of Patient-Derived Non-Small Cell Lung Cancer Xenografts as Models for the Identification of Predictive Biomarkers
Clin. Cancer Res., October 15, 2008; 14(20): 6456 - 6468.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
E. S. Schernhammer, E. Giovannuccci, C. S. Fuchs, and S. Ogino
A Prospective Study of Dietary Folate and Vitamin B and Colon Cancer According to Microsatellite Instability and KRAS Mutational Status
Cancer Epidemiol. Biomarkers Prev., October 1, 2008; 17(10): 2895 - 2898.
[Abstract] [Full Text] [PDF]

Home page
 J. Mol. Diagn.Home page
D. T. Croft Jr, R. M. Jordan, H. L. Patney, C. D. Shriver, M. N. Vernalis, T. J. Orchard, and D. L. Ellsworth
Performance of Whole-Genome Amplified DNA Isolated from Serum and Plasma on High-Density Single Nucleotide Polymorphism Arrays
J. Mol. Diagn., May 1, 2008; 10(3): 249 - 257.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
N. S. Butler, A. Theodossis, A. I. Webb, M. A. Dunstone, R. Nastovska, S. H. Ramarathinam, J. Rossjohn, A. W. Purcell, and S. Perlman
Structural and Biological Basis of CTL Escape in Coronavirus-Infected Mice
J. Immunol., March 15, 2008; 180(6): 3926 - 3937.
[Abstract] [Full Text] [PDF]

Home page
 J. Mol. Diagn.Home page
S. Ogino and A. Goel
Molecular Classification and Correlates in Colorectal Cancer
J. Mol. Diagn., January 1, 2008; 10(1): 13 - 27.
[Abstract] [Full Text] [PDF]

Home page
 GutHome page
S. Ogino, T. Kawasaki, G. J Kirkner, Y. Suemoto, J. A Meyerhardt, and C. S Fuchs
Molecular correlates with MGMT promoter methylation and silencing support CpG island methylator phenotype-low (CIMP-low) in colorectal cancer
Gut, November 1, 2007; 56(11): 1564 - 1571.
[Abstract] [Full Text] [PDF]

Home page
 J. Mol. Diagn.Home page
C. Spittle, M. R. Ward, K. L. Nathanson, P. A. Gimotty, E. Rappaport, M. S. Brose, A. Medina, R. Letrero, M. Herlyn, and R. H. Edwards
Application of a BRAF Pyrosequencing Assay for Mutation Detection and Copy Number Analysis in Malignant Melanoma
J. Mol. Diagn., September 1, 2007; 9(4): 464 - 471.
[Abstract] [Full Text] [PDF]

Home page
 J. Mol. Diagn.Home page
E. Dejeux, V. Audard, C. Cavard, I. G. Gut, B. Terris, and J. Tost
Rapid Identification of Promoter Hypermethylation in Hepatocellular Carcinoma by Pyrosequencing of Etiologically Homogeneous Sample Pools
J. Mol. Diagn., September 1, 2007; 9(4): 510 - 520.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
S. Ogino, A. Hazra, G. J. Tranah, G. J. Kirkner, T. Kawasaki, K. Nosho, M. Ohnishi, Y. Suemoto, J. A. Meyerhardt, D. J. Hunter, et al.
MGMT germline polymorphism is associated with somatic MGMT promoter methylation and gene silencing in colorectal cancer
Carcinogenesis, September 1, 2007; 28(9): 1985 - 1990.
[Abstract] [Full Text] [PDF]

Home page
 J. Mol. Diagn.Home page
S. Ogino, T. Kawasaki, G. J. Kirkner, P. Kraft, M. Loda, and C. S. Fuchs
Evaluation of Markers for CpG Island Methylator Phenotype (CIMP) in Colorectal Cancer by a Large Population-Based Sample
J. Mol. Diagn., July 1, 2007; 9(3): 305 - 314.
[Abstract] [Full Text] [PDF]

Home page
 J. Mol. Diagn.Home page
S. Ogino, T. Kawasaki, G. J. Kirkner, M. Loda, and C. S. Fuchs
CpG Island Methylator Phenotype-Low (CIMP-Low) in Colorectal Cancer: Possible Associations with Male Sex and KRAS Mutations
J. Mol. Diagn., November 1, 2006; 8(5): 582 - 588.
[Abstract] [Full Text] [PDF]

Home page
 GutHome page
S Ogino, M Cantor, T Kawasaki, M Brahmandam, G J Kirkner, D J Weisenberger, M Campan, P W Laird, M Loda, and C S Fuchs
CpG island methylator phenotype (CIMP) of colorectal cancer is best characterised by quantitative DNA methylation analysis and prospective cohort studies
Gut, July 1, 2006; 55(7): 1000 - 1006.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
S. Ogino, J. A. Meyerhardt, M. Cantor, M. Brahmandam, J. W. Clark, C. Namgyal, T. Kawasaki, K. Kinsella, A. L. Michelini, P. C. Enzinger, et al.
Molecular Alterations in Tumors and Response to Combination Chemotherapy with Gefitinib for Advanced Colorectal Cancer
Clin. Cancer Res., September 15, 2005; 11(18): 6650 - 6656.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by the American Society for Investigative Pathology and the Association for Molecular Pathology.